Activity and safety of combination chemotherapy with methotrexate, ifosfamide, l-asparaginase and dexamethasone (MILD) for refractory lymphoid malignancies: a pilot study.

Tsukune, Yutaka; Isobe, Yasushi; Yasuda, Hajime; Shimizu, Seiichi; Katsuoka, Yuna; Hosone, Masaru; Oshimi, Kazuo; Komatsu, Norio; Sugimoto, Koichi

Tsukune, Yutaka; Isobe, Yasushi; Yasuda, Hajime; Shimizu, Seiichi; Katsuoka, Yuna; Hosone, Masaru; Oshimi, Kazuo; Komatsu, Norio; Sugimoto, Koichi.

Affiliation

Tsukune Y; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.

Eur J Haematol ; 84(4): 310-5, 2010 Apr.

Article in En | MEDLINE | ID: mdl-20015242

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Hematologic Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Asparaginase/administration & dosage; Asparaginase/adverse effects; Female; Humans; Ifosfamide/administration & dosage; Ifosfamide/adverse effects; Lymphopenia/chemically induced; Male; Methotrexate/administration & dosage; Methotrexate/adverse effects; Middle Aged; Mucormycosis/chemically induced; Neutropenia/chemically induced; Pilot Projects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Hematologic Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2010 Type: Article

Fulltext

XML

PubMed Links

Search on Google